Stock A214450 PHARMARESEARCH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News PharmaResearch Co., Ltd.

Equities

A214450

KR7214450009

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
139,600 KRW +8.55% Intraday chart for PharmaResearch Co., Ltd. +17.51% +27.49%
2023 PharmaResearch Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2021 PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaResearch Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
PharmaResearch acquires patent registration on bone grafting composition in China
AQ
High Concentration Nucleic Acid Liquid Composition Patent Registration is Confirmed in Japan
AQ
PharmaResearch Participates in South Korea's Largest Medical Exhibition - KIMES 2022
AQ
PharmaResearch acquires a patent for filler composition for molding filling composition for tissue enhancement
AQ
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd.
CI
PharmaResearch Acquires Medicoson, Medical Electronics Company
AQ
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd.
CI
PharmaResearch Co., Ltd. acquired Medicoson Co., Ltd.
CI
PharmaResearch Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
CI
PharmaResearch Co., Ltd. announced that it expects to receive KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm
CI
PharmaResearch : acquires Japanese patent for articular cavity injection comprising nucleic acid and chitosan
AQ
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.
CI
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.
CI
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.
CI
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.
CI
Pharma Research Products Co., Ltd's Equity Buyback announced on February 21, 2019, has expired with 129,237 shares, representing 1.37% for KRW 4,992.18 million.
CI
Pharma Research Products Co., Ltd's Equity Buyback Plan Extended till February 21, 2020.
CI
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.
CI
Pharma Research Products Co., Ltd announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A214450 Stock
  4. News PharmaResearch Co., Ltd.